Affiliation:
1. St. Vincent Hospital and Medical Center, Portland, Oregon 97225.
Abstract
Susceptibility to sparfloxacin was tested simultaneously by the agar dilution and disk diffusion methods. For tests with 5-micrograms sparfloxacin disks, we propose that the breakpoints for the susceptibility and resistance categories should be > or = 19 and < or = 15 mm, respectively. Most minor discrepancies involved tests with pseudomonads.
Publisher
American Society for Microbiology
Reference10 articles.
1. Barry A. L. and P. C. Fuchs. 1991. Sparfloxacin in vitro antibacterial activity compared to that of ciprofloxacin and ofloxacin. Proc. 17th Int. Congr. Chemother. Berlin Germany abstr. 2037.
2. In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin;Barry A. L.;Antimicrob. Agents Chemother.,1991
3. In vitro activity of sparfloxacin, a new quinolone antimicrobial agent;Cooper M. A.;J. Antimicrob. Chemother.,1990
4. In vitro activity of sparfloxacin (AT-4140, CI-978, PD 131,501), a new quinolone antimicrobial agent;Eliopoulos G. M.;Diagn. Microbiol. Infect. Dis.,1990
5. Pharmacokinetics and inflammatory fluid penetration of sparfloxacin;Johnson J. H.;Antimicrob. Agents Chemother.,1992
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献